ESR1 and rheumatoid arthritis: The poor responders had significantly higher DAS28-ESR at baseline, SJC28, TJC28, ESR, CRP, PtGA, PhGA, and HAQ and longer RA duration, but lower percentage of glucocorticoid users at baseline, compared to the good responders (Table 1).